Citation Impact
Citing Papers
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
2013 Standout
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
2008
World Health Organization reference values for human semen characteristics*‡
2009 Standout
Sexual function in endometriosis patients and their partners: effect of the disease and consequences of treatment
2016
Sex Differences in Pharmacokinetics and Pharmacodynamics
2009
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
Sex bias in neuroscience and biomedical research
2010 Standout
Biochemical and Physiological Aspects of Endogenous Androgens
2009
A Dose‐Response Study of Testosterone on Sexual Dysfunction and Features of the Metabolic Syndrome Using Testosterone Gel and Parenteral Testosterone Undecanoate
2007
The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval
2015
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Salivary cortisol as a biomarker in stress research
2008 Standout
Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial
2008
Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?
2013
Combined oral contraceptives in the treatment of polycystic ovary syndrome
2005
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Oral Contraceptive Use and Bone Density Change in Adolescent and Young Adult Women: A Prospective Study of Age, Hormone Dose, and Discontinuation
2011
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Pharmacokinetics of Testosterone Undecanoate Injected Alone or in Combination With Norethisterone Enanthate in Healthy Men
2006
Contraceptive Technology
2021 Standout
A randomized, double‐blind, placebo‐controlled trial on the effect of long‐acting testosterone treatment as assessed by the Aging Male Symptoms scale
2011
Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins
2006
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Sex differences in immune responses
2016 Standout
Endometriosis: pathogenesis and treatment
2013 Standout
Polycystic ovary syndrome
2016 Standout
Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate
2020
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Sex hormones and the immune response in humans
2005
Oral Contraception Does Not Alter Single Dose Saquinavir Pharmacokinetics in Women
2004
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
Haemostatic variables during normal menstrual cycle
2011
Oestrogen exposure and breast cancer risk
2003
A comparative study on the effects of a contraceptive vaginal ring NuvaRing®and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function
2004
Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β‐estradiol in comparison to levonorgestrel/ethinylestradiol
2012
Combination contraceptives: effects on weight
2014
Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control
2017
Sex Differences in Pharmacokinetics and Pharmacodynamics
2004
Mortality in Patients with Pituitary Disease
2010
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
The Effect of Efavirenz on the Pharmacokinetics of An Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy HIV-Negative Women
2010
Effect of Ginger (Zingiber officinale) on Heavy Menstrual Bleeding: A Placebo‐Controlled, Randomized Clinical Trial
2014
New Reference Intervals for Thyrotropin and Thyroid Hormones Based on National Academy of Clinical Biochemistry Criteria and Regular Ultrasonography of the Thyroid
2005
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Types of progestogens in combined oral contraception: effectiveness and side-effects
2011
The Metabolic Syndrome
2008 Standout
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)
2019 Standout
Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method
2019
Effects of Testosterone Undecanoate Administered Alone or in Combination with Letrozole or Dutasteride in Female to Male Transsexuals
2008
Industry sponsorship and research outcome
2017 Standout
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus
2014
Works of Uwe Mellinger being referenced
Change to Either a Nonandrogenic or Androgenic Progestin-Containing Oral Contraceptive Preparation is Associated with Improved Sexual Function in Women with Oral Contraceptive-Associated Sexual Dysfunction
2013
Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, double-blind, active-controlled HARMONY II study
2013
Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?
1998
Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest — a dose-ranging study
2000
Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive
2011
Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy
2011
Intramuscular Testosterone Undecanoate: Pharmacokinetic Aspects of a Novel Testosterone Formulation during Long-Term Treatment of Men with Hypogonadism
2004
Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial
2011
Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest
2011
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins
2003
Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population
2014
Effect of dienogest-containing oral contraceptives on lipid metabolism
2002
A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system
2000
Effective Treatment of Heavy Menstrual Bleeding With Estradiol Valerate and Dienogest
2011
Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 μg ethinyl estradiol and 2.00 mg dienogest on the hemostatic system
1997
Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters
2003
Effects of Combined Oral Contraceptive Ethinylestradiol (30 μg) and Dienogest (2 mg) on Carbohydrate Metabolism During 1 Year of Conventional or Extended-Cycle Use
2010
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel
2009
Efficacy and Safety of a Combined Oral Contraceptive Containing Estradiol Valerate/Dienogest: Results from a Clinical Study Conducted in North America
2013
Influence of Dienogest on Ovulation in Young Fertile Women
1999
Hormone withdrawal-associated symptoms: Comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate
2013
Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive
2011